Venetoclax shows potential for R/R hairy cell leukemia

Published Date: 13 Mar 2023

Five out of six patients with relapsed or recurrent lymphoma responded to venetoclax alone or in combination with rituximab.

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Study finds 10% of pediatric blood cancers may stem from medical imaging radiation

2.

A single bout of exercise gives results that could help cancer patients

3.

Cancer Vaccines' Emergence; More Focus on Side Effects; A Nudge for Exercise.

4.

Survival improved with lobectomy, segmentectomy in early non-small cell lung cancer

5.

We Can Advance Our Patients' Healing by One Step With 1,000 Paper Cranes.


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot